Literature DB >> 7157213

Early effects of intravenous terbutaline on cardiopulmonary function in chronic obstructive bronchitis and pulmonary hypertension.

R M Jones, R A Stockley, J M Bishop.   

Abstract

Terbutaline sulphate (0.25 mg) was given intravenously to 10 recumbent patients with severe irreversible airflow obstruction and pulmonary hypertension who were undergoing right heart catheterisation. Alveolar ventilation index, cardiac index, and mean pulmonary artery pressure all rose significantly at 5 minutes and then fell by 35 minutes, although the first two remained higher than control levels. This was accompanied by a small but significant rise in arterial oxygen tension at 5 minutes. There were no significant changes in ventilation-perfusion relationships at either 5 or 35 minutes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7157213      PMCID: PMC459419          DOI: 10.1136/thx.37.10.746

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Bronchodilator effect and effect on blood gases after subcutaneous injection and inhalation of terbutaline.

Authors:  K Holten
Journal:  Br J Dis Chest       Date:  1974-04

2.  Comparison of cardiorespiratory effects of terbutaline and salbutamol aerosols in patients with reversible airways obstruction.

Authors:  L Harris
Journal:  Thorax       Date:  1973-09       Impact factor: 9.139

3.  Circulatory effects of orciprenaline, adrenaline and a new sympathomimetic beta-receptor-stimulating agent, terbutaline, in normal human subjects.

Authors:  B Arner; A Bertler; T Karlefors; H Westling
Journal:  Acta Med Scand Suppl       Date:  1970

4.  The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis.

Authors:  P Harris; N Segel; J M Bishop
Journal:  Cardiovasc Res       Date:  1968-01       Impact factor: 10.787

5.  Comparison of the effect on blood gases, ventilation, and perfusion of isoproterenol-phenylephrine and salbutamol aerosols in chronic bronchitis with asthma.

Authors:  L Harris
Journal:  J Allergy Clin Immunol       Date:  1972-02       Impact factor: 10.793

6.  An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects.

Authors:  R J Knudson; H P Constantine
Journal:  J Appl Physiol       Date:  1967-03       Impact factor: 3.531

7.  Comparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutaline in patients with reversible airway obstruction.

Authors:  D W Amory; S C Burnham; F W Cheney
Journal:  Chest       Date:  1975-03       Impact factor: 9.410

8.  Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men.

Authors:  A G Leitch; L J Clancy; J F Costello; D C Flenley
Journal:  Br Med J       Date:  1976-02-14

9.  Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale.

Authors:  R A Stockley; P Finnegan; J M Bishop
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139

10.  Effects of isoprenaline plus phenylephrine by pressurized aerosol on blood gases, ventilation, and perfusion in chronic obstructive lung disease.

Authors:  L H Harris
Journal:  Br Med J       Date:  1970-12-05
View more
  3 in total

Review 1.  Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema?

Authors:  K F Whyte; D C Flenley
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

2.  Drugs or oxygen for hypoxic cor pulmonale?

Authors:  P Howard
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

3.  Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.

Authors:  W MacNee; C G Wathen; W J Hannan; D C Flenley; A L Muir
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.